Responses
Rheumatology
Original research
Interruptions of biological and targeted synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: a descriptive cohort study assessing trends in patient characteristics in Switzerland
Compose a Response to This Article
Other responses
No responses have been published for this article.